lightvalley

GlaxoSmithKline to Acquire Genelabs Technologies For $57M

This is a low bal offer. Onan adjusted basis this stock once traded at around $10 per share and the fifty two week high is around $2 while the 104 weeek is about twice that.

DO NOT accept the first round offer. Those buying this stock are smart, they are paying less becaseeu of the broad market dip! Heck buy GSK if you must ! ! !

We can get closer to $5 dollars per share, I believe.